Findings indicate that WHO-5 and PWB-6 are valid indices of psychological well-being that may provide unique prognostic information and help researchers and clinicians tailor personalized treatment strategies. The two PROMs can be used jointly but for different clinical purposes. WHO-5 is particularly suitable to assess the degree of subjective vitality, a positive feeling of aliveness and energy that may help SSc patients cope with their illness. The PWB-6 can be used to identify unique experiences of psychological well-being that may help SSc patients not only cope with their feelings of loneliness and uncertainty but also experience a meaningful life despite the progression of disease. In clinical research and daily practice, the baseline and follow-up use of WHO-5 and PWB-6 may thus lead to a substantial improvement in the quality of care of patients with SSc. Given the cross-sectional design of the present investigation, future prospective studies are, however, recommended to further assess the predictive validity and prognostic utility of the two PROMs.
No takes yet. Share an insight, caveat, or question.
Carrozzino et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: